Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU Produces More Guidance For Upcoming Clinical Trials Regulation

Executive Summary

The European Commission has issued a new template on trial recruitment and informed consent procedures and has updated its guidance on the provisions of the EU Clinical Trials Regulation that allow a trial to be conditionally authorized. 

You may also be interested in...



EU Offers More Clarity On Complying With Upcoming Clinical Trials Regulation

The European Commission has updated its guidance on the technical aspects of the Clinical Trials Regulation to clarify expectations on topics such as expanding authorized trials to additional EU member states and complying with safety reporting requirements.

EU Explains How Info Requests Will Be Managed Under Clinical Trials Regulation

Updated guidance on the upcoming EU Clinical Trials Regulation deals with requests for information from the regulators and how strict timelines for evaluating clinical trial applications will be adhered to. 

WHO Examines Ethical Criteria For Human Challenge Trials Ahead Of Next Health Emergency

The World Health Organization is looking to finalize its guidance on the ethical criteria that should be applied to studies that involve deliberately infecting healthy individuals to speed up research.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS141287

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel